Global Macular Degeneration Treatment Market Report 2023: Sector is Expected to Reach $1.9 Billion by 2028 at a CAGR of 6.38% - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Macular Degeneration Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.

The global macular degeneration treatment market size reached US$ 8.9 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 12.9 Billion by 2028, exhibiting a CAGR of 6.38% during 2022-2028.

Companies Mentioned

• Aerie Pharmaceuticals Inc.
• Bausch Health Companies Inc.
• Bayer AG
• F. Hoffmann-La Roche Ltd
• Iveric Bio Inc.
• Novartis AG
• Panoptica
• Pfizer Inc.
• Phio Pharmaceuticals
• Regeneron Pharmaceuticals Inc.
• Regenxbio Inc.
• Santen Pharmaceutical Co. Ltd.

Macular degeneration is a neurodegenerative ocular disorder that affects the eyes and causes blurred or loss of vision in the center of the visual field. It is characterized by blind spots in the field of vision, visual distortions and inability to see in low light conditions. Some of the commonly used therapeutic techniques for macular degeneration includes anti-angiogenic drugs, photodynamic laser therapies, contact lenses and transitional lenses.

Laser therapy involves the insertion of specialized contact lenses into the affected are of the eye, which are sealed by lasers along with the blood vessels. Anti-angiogenic drugs are used for preventing blockages and leakages in the blood vessels. Timely treatment of macular degeneration treatment can aid in enhancing vision and minimizing the risks of developing chronic blindness.

The increasing incidences of age-related macular degeneration and obesity among the masses is one of the key factors driving the market growth. The changing dietary patterns and the rising adoption of sedentary lifestyles is leading to the development of macular degeneration.

Additionally, the increasing utilization of smartphones, laptops and television, which is leading to prolonged and excessive screen time is also impacting the occurrence of the disorder. Moreover, the development of retinal gene therapies that involves the injection of adeno-associated virus (AAV) into the body for preventing the development of abnormal blood vessels is providing a thrust to the market growth. In line with this, significant improvements in the healthcare infrastructure is positively impacting the market growth.

Other factors, including extensive research and development (R&D) activities for the development of innovative and effective drugs, along with the implementation of various government initiatives for promoting public health, are anticipated to drive the market toward growth.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global macular degeneration treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, stage of disease, route of administration and end user.

Breakup by Type:

• Dry Age-related Macular Degeneration
• Wet Age-related Macular Degeneration

Breakup by Stage of Disease:

• Early Stage
• Intermediate Stage
• Late Stage

Breakup by Route of Administration:

• Intravenous Route
• Intravitreal Route

Breakup by End User:

• Hospitals
• Ambulatory Surgical Center
• Others

Key Questions Answered in This Report

1. What was the size of the global macular degeneration treatment market in 2022?

2. What is the expected growth rate of the global macular degeneration treatment market during 2023-2028?

3. What are the key factors driving the global macular degeneration treatment market?

4. What has been the impact of COVID-19 on the global macular degeneration treatment market?

5. What is the breakup of the global macular degeneration treatment market based on the type?

6. What is the breakup of the global macular degeneration treatment market based on the stage of disease?

7. What is the breakup of the global macular degeneration treatment market based on the route of administration?

8. What is the breakup of the global macular degeneration treatment market based on the end user?

9. What are the key regions in the global macular degeneration treatment market?

10. Who are the key players/companies in the global macular degeneration treatment market?

For more information about this report visit https://www.researchandmarkets.com/r/wfv8oa

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900